Eiko LifeSciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	21.06	7.52	7.69	7.06	6.14
Depreciation & Amortization	7.37	6.63	6.33	5.62	0.62
Loss (Gain) From Sale of Assets	-0	-	-	-	-
Loss (Gain) From Sale of Investments	-0.15	-	-0.32	-	-
Other Operating Activities	-2.25	1.59	-2.44	-1.53	-2.33
Change in Accounts Receivable	23.48	-60.28	-25.43	-11.48	-34.15
Change in Inventory	-23.89	-24.78	45.5	-53.94	-0.64
Change in Accounts Payable	19.34	3.35	-3.03	-5.47	18.95
Change in Other Net Operating Assets	-15.72	-4.82	13.94	-17.54	3.16
Operating Cash Flow	29.24	-70.8	42.24	-77.27	-8.25
Capital Expenditures	-102.91	-3.47	-2.25	-1.55	-
Investment in Securities	-31.22	-39.64	2.1	-0.03	4.03
Other Investing Activities	19.69	37.62	8.89	6.42	3.58
Investing Cash Flow	-114.45	-5.49	8.75	5.92	-29.36
Long-Term Debt Issued	27.63	-	-	27.95	15.63
Total Debt Issued	27.63	-	-	27.95	15.63
Long-Term Debt Repaid	-	-	-45.53	-	-
Total Debt Repaid	-	-	-45.53	-	-
Net Debt Issued (Repaid)	27.63	-	-45.53	27.95	15.63
Issuance of Common Stock	43.46	205.05	-	9.5	63.4
Other Financing Activities	-1.54	-1.42	-1.5	-4.64	-0.88
Financing Cash Flow	69.56	203.62	-47.04	32.8	78.15
Miscellaneous Cash Flow Adjustments	-0	-0	0	-	-
Net Cash Flow	-15.65	127.34	3.95	-38.55	40.54
Free Cash Flow	-73.67	-74.26	39.99	-78.82	-8.25
Free Cash Flow Margin	-19.56%	-26.59%	21.83%	-31.02%	-6.88%
Free Cash Flow Per Share	-5.65	-7.20	4.09	-10.09	-2.16
Cash Interest Paid	1.59	1.42	1.5	4.64	0.88
Cash Income Tax Paid	3.09	0.34	-0.75	2.11	1.82
Levered Free Cash Flow	-78.93	-77.13	47.74	-92.58	-63.62
Unlevered Free Cash Flow	-77.97	-76.25	48.67	-90.27	-63.07
Change in Working Capital	3.21	-86.53	30.98	-88.43	-12.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.